SIAG
PFE icon

Signet Investment Advisory Group’s Pfizer PFE Stock Holding History

Signet Investment Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
159,718
+4,953
+3% +$130K 1.69% 23
2026
Q1 		$4.35M Buy
154,765
+5,465
+4% +$145K 1.99% 19
2025
Q4 		$3.72M Buy
149,300
+2,421
+2% +$61.1K 1.73% 23
2025
Q3 		$3.74M Buy
146,879
+11,567
+9% +$285K 1.8% 23
2025
Q2 		$3.28M Buy
135,312
+3,194
+2% +$74.5K 1.68% 23
2025
Q1 		$3.35M Buy
132,118
+8,932
+7% +$234K 1.69% 22
2024
Q4 		$3.27M Buy
123,186
+4,152
+3% +$113K 1.67% 23
2024
Q3 		$3.44M Buy
119,034
+2,507
+2% +$73.1K 1.72% 21
2024
Q2 		$3.26M Buy
116,527
+3,915
+3% +$108K 1.75% 20
2024
Q1 		$3.12M Buy
112,612
+6,500
+6% +$180K 1.71% 22
2023
Q4 		$3.05M Buy
106,112
+4,045
+4% +$122K 1.84% 18
2023
Q3 		$3.39M Buy
102,067
+2,260
+2% +$79.9K 2.25% 15
2023
Q2 		$3.66M Buy
99,807
+1,344
+1% +$52.3K 2.42% 12
2023
Q1 		$4.02M Buy
98,463
+8,196
+9% +$354K 2.77% 7
2022
Q4 		$4.63M Sell
90,267
-593
-0.7% -$28.4K 3.26% 6
2022
Q3 		$3.98M Buy
90,860
+386
+0.4% +$18.8K 3.08% 7
2022
Q2 		$4.74M Sell
90,474
-1,869
-2% -$95.2K 3.29% 6
2022
Q1 		$4.78M Sell
92,343
-2,535
-3% -$132K 2.87% 6
2021
Q4 		$5.6M Buy
94,878
+22
+0% +$1.09K 3.19% 6
2021
Q3 		$4.08M Buy
94,856
+4,504
+5% +$200K 2.57% 8
2021
Q2 		$3.54M Buy
90,352
+5,703
+7% +$222K 2.28% 10
2021
Q1 		$3.07M Buy
84,649
+2,411
+3% +$85.6K 2.38% 12
2020
Q4 		$3.03M Buy
+82,238
New +$3.02M 2.39% 11
2019
Q4 		$2.45M Buy
65,946
+480
+0.7% +$17.1K 2.28% 14
2019
Q3 		$2.23M Sell
65,466
-1,459
-2% -$53.1K 2.27% 16
2019
Q2 		$2.75M Sell
66,925
-3,316
-5% -$132K 2.87% 9
2019
Q1 		$2.83M Sell
70,241
-372
-0.5% -$14.9K 3.01% 7
2018
Q4 		$2.92M Buy
+70,613
New +$2.93M 3.28% 6

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Signet Investment Advisory Group's PFE Position: Q2 2026 in Review

Signet Investment Advisory Group increased its Pfizer (PFE) stake by 3.2% in Q2 2026, buying an estimated $130K and bringing the position to 159,718 shares worth $3.85M. The position accounts for 1.69% of the portfolio, ranked #23.

Signet Investment Advisory Group first reported a position in PFE in Q4 2018 and has held it in 28 quarters since. The position peaked at $5.6M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Signet Investment Advisory Group held 159,718 shares of Pfizer worth $3.85M as of Q2 2026.
  • Signet Investment Advisory Group bought 4,953 Pfizer shares in Q2 2026, an estimated $130K.
  • Pfizer made up 1.69% of Signet Investment Advisory Group's portfolio in Q2 2026, its #23 holding.
  • Signet Investment Advisory Group first reported a position in Pfizer in Q4 2018 and has held it in 28 quarters since.
  • Signet Investment Advisory Group's Pfizer position peaked at $5.6M in Q4 2021.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Signet Investment Advisory Group's 13F filing for Q2 2026, filed 30 Jul 2026.